KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.6100
+0.0700 (+4.55%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close1.5400
Open1.5400
Bid1.60 x 0
Ask1.61 x 0
Day's Range1.5400 - 1.6100
52 Week Range0.8700 - 2.0700
Volume314,543
Avg. Volume576,854
Market Cap120.819M
Beta (3Y Monthly)0.63
PE Ratio (TTM)N/A
EPS (TTM)-0.40
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.40
  • CNW Group2 days ago

    Khiron Life Sciences Launches Latin American Medical Education Program With Events in Colombia and Mexico

    TORONTO , Jan. 18, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has launched its Latin America medical education program with a schedule of doctor training and learning events in Bogota, Colombia on January 21-23 , and in Mexico City, Mexico on February 28 .

  • CNW Group3 days ago

    Khiron Life Sciences Announced as Co-Host of Cannamexico World Summit 2019

    TORONTO , Jan. 17, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company will co-host Cannamexico World Summit 2019, a comprehensive cannabis symposium taking place April 25 - 26 at Centro Fox , Guanajuato, Mexico . This is the second annual Cannamexico event and is recognized as the first of its kind cannabis summit in Mexico .

  • CNW Group9 days ago

    Khiron Life Sciences to Present as Lead Sponsor in First CannaTech Panama Global Medical Cannabis Summit

    TORONTO , Jan. 11, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company will be title sponsor of the first Cannatech Panama summit taking place February 12-13 in Panama City, Panama . Khiron will be prominently featured throughout the summit and key members of the Company's senior medical and compliance team will deliver session presentations on global medical cannabis patient, research and compliance topics with particular impact in Latin America .

  • CNW Group20 days ago

    Khiron Life Sciences Added to Horizons Marijuana Life Sciences Index ETF

    TORONTO , Dec. 31, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has been added to the Horizons Marijuana Life Sciences Index ETF ("HMMJ:TSX"), marking the Company's elevation to the senior index of publicly traded North American companies with significant business activity in the cannabis industry.

  • GlobeNewswirelast month

    Uptick Newswire Hosts Khiron Life Sciences Corp.’s President to Discuss the Growing Latin American Cannabis Market and How They Have Positioned Themselves as a Leader

    “Khiron is positioned to be the dominant integrated medical cannabis company in Latin America,” Naprawa said as he started the interview. Naprawa went on to say they’ve been at this for two years and have assembled an elite group of people and have a $75 million market share cap.

  • GlobeNewswirelast month

    Khiron Life Sciences Completes Acquisition of ILANS

    TORONTO, Dec. 13, 2018 -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with.

  • CNW Grouplast month

    Khiron Life Sciences Receives Endorsement from Prominent Colombian Medical Association for the Study of Pain

    TORONTO , Dec. 11, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce it has signed an endorsement agreement with the highly respected and influential Colombian Association for the Study of Pain (ACED). In endorsing Khiron's patient-focused approach to medical cannabis research and product development, ACED has committed to partnering with the Company on a schedule of patient and physician education programs, modules and events.

  • Market Exclusive2 months ago

    Khiron Life Nears Launching Nutraceutical Products in Mexico

    Medical cannabis firm Khiron Life Sciences (OTCQB: KHRNF) announced that its subsidiary Kuida Life Mexico S.A. received approval from Mexico’s Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to import and commercialize three products of the company’s Nutraceutical Line. The approved initial products include; a CBD (cannabidiol) based formulation designed to help promote sleep; […] The post Khiron Life Nears Launching Nutraceutical Products in Mexico appeared first on Market Exclusive.

  • CNW Group2 months ago

    Khiron Life Sciences Enters Mexican Cannabis Market With The Launch of Its First Nutraceutical Product Line

    TORONTO , Dec. 3, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that its wholly-owned subsidiary, Kuida Life Mexico S.A., has received approval from Mexico's Federal Commission for the Protection against Sanitary Risk  (COFEPRIS) to import and commercialize three products of the Company's Nutraceutical Line. The commencement of sales in Mexico is subject to prior TSX Venture Exchange ("TSXV") approval.

  • GlobeNewswire2 months ago

    Khiron Life Sciences Reports Third Quarter Fiscal 2018 Financial Results

    Khiron Life Sciences Corp. (“Khiron” or the “Company”) (KHRN.V) (KHRNF) (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today its financial results for the third quarter ended September 30, 2018. Appointed Mr. Vicente Fox to the Khiron Board of Directors. Mr. Fox is the former CEO of Coca Cola Mexico, former President of Mexico and a significant advocate for the legalization of cannabis in Mexico.

  • CNW Group2 months ago

    Khiron Life Sciences Enters Peruvian Cannabis Market With Approval For Commercialization Of Kuida® CBD Cosmeceutical Brand

    TORONTO , Nov. 27, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has received approval to commercialize and market four key products in the Company's Kuida® CBD cosmeceutical product line in Peru . This approval, from Peru's Executive Director of the Directorate of Medical Devices and Health Products of the General Directorate of Medications, Supplies and Drugs (DIGEMID) brings Kuida® product to a population of 32 Million people in Peru , and with previously announced agreements in Colombia and Mexico , positions the Kuida® brand to now be marketed to a combined population of almost 200 Million in Latin America .

  • CNW Group2 months ago

    Khiron Life Sciences Achieves Milestone With Additional Cultivation Quotas From The Colombian Technical Quotas Group

    TORONTO , Nov. 19, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce that it has received additional quotas from the Colombian Technical Quotas Group ("TQG"), to cultivate 5,040 psychoactive cannabis plants for the purposes of completing the Colombian Agricultural Institute ("ICA") agronomic evaluation tests. This represents a key milestone towards Khiron's stated timeline to bring medical cannabis options to market in Colombia .

  • PR Newswire2 months ago

    Khiron Life Sciences Announces Completion of Warrant Acceleration

    TORONTO, Nov. 15, 2018 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce that the Company has received  $14,007,000 from the exercise of warrants of which the expiry date was accelerated to November 14, 2018 (the "Warrants"), as previously announced on October 25, 2018. Khiron Life Sciences Corp.  (TSXV: KRHN, OTCQB: KHRNF, Frankfurt: A2JMZC) ("Khiron" or the "Company") is positioned to be the dominant integrated medical cannabis company in Latin America.

  • CNW Group2 months ago

    Khiron Life Sciences Announces Completion of Warrant Acceleration

    TORONTO , Nov. 15, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , is pleased to announce that the Company has received  $14,007,000 from the exercise of warrants of which the expiry date was accelerated to November 14, 2018 (the "Warrants"), as previously announced on October 25, 2018 . Khiron Life Sciences Corp.  (TSXV: KRHN, OTCQB: KHRNF, Frankfurt : A2JMZC) ("Khiron" or the "Company") is positioned to be the dominant integrated medical cannabis company in Latin America .

  • CNW Group2 months ago

    Khiron Life Sciences Welcomes Cannabis Legislation Proposed by Incoming Government of Mexico

    TORONTO , Nov. 8, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , welcomes the initiative presented today by the incoming Government of Mexico through its next secretary of the Interior, Dr. Olga Sánchez Cordero, for the Regulation and Control of Cannabis in Mexico . The General Law for the Regulation and Control of Cannabis, presented by Dr. Olga Sanchez will establish Mexico among Latin American countries that have legislated the use of cannabis for recreational, medical, scientific, research, industrial and commercial purposes.  Mexico has the second largest population in Latin America and 11.7 million potential patients for medical cannabis.

  • CNW Group2 months ago

    Khiron Life Sciences Announces Mexican Retail Distribution for Kuida® CBD Cosmeceutical Brand

    TORONTO , Nov. 6, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has extended an agreement with Farmalisto, the regions leading digital drugstore, to market and distribute the Company's Kuida®  CBD cosmeceutical brand to a population of over 120 million consumers in Mexico , subject to approvals from the Federal Commission for the Protection of Health Risks (COFEPRIS).

  • CNW Group2 months ago

    Khiron Life Sciences Applauds Government of Mexico on Announcing Guidelines for the Production and Import of Medical Cannabis Products

    TORONTO , Nov. 5, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , applauds today's announcement by the Government of Mexico establishing guidelines for the sanitary control of cannabis and its extracts. In today's announcement made by Mr. Julio Sánchez y Tepóz, Federal Commissioner of COFEPRIS, the commission laid out the key components of the provision, medical and scientific research and types of cannabis products.

  • CNW Group3 months ago

    Khiron Secures Endorsement from the Leading Palliative Care Association in Colombia

    TORONTO , Oct. 26, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has signed an exclusive agreement with the Colombian Association of Palliative Care (ACCP), the leading network of pain and palliative care specialists in Colombia .

  • CNW Group3 months ago

    Khiron Life Sciences Announces Acceleration of Expiry Date of Warrants

    TORONTO , Oct. 25, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN, OTCQB: KHRNF, Frankfurt : A2JMZC), a Canadian integrated medical cannabis company with its core operations in Colombia , is pleased to announce that the Company has elected to exercise its right under the warrant indenture (the "Indenture") governing the common share purchase warrants of the Company (the "Warrants") issued on January 12, 2018 . Pursuant to the terms of the Indenture, the Company may accelerate the expiry date of the Warrants when the closing price of the common shares of the Company (the "Common Shares") on the TSX Venture Exchange exceeds $1.40 for a period of 10 consecutive trading days in any 30 trading day period (the "Acceleration Event").

  • CNW Group3 months ago

    Khiron Life Sciences Announces Launch of Khiron Clinics With the Signing of the Definitive Agreement to Acquire ILANS

    TORONTO , Oct. 24, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , has signed the definitive agreement for the acquisition of the Latin American Institute of Neurology and the Nervous System ("ILANS") previously announced on August 7, 2018 . ILANS is one of the most respected, fastest growing, and largest neurological clinics in Colombia , and becomes a cornerstone of the Khiron Clinics business unit in Latin America .

  • CNW Group4 months ago

    Khiron Life Sciences Corp. Announces Colombian Retail Distribution Partners for Kuida® CBD Cosmeceutical Brand

    TORONTO , Oct. 2, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that it has signed multi-channel distribution agreements for Kuida®, its first CBD-based skincare brand. As part of a robust strategy, Kuida® launches with secured distributor agreements that leverage their market reach, geographic location, scale and ability to ensure the Kuida® brand achieves its market potential.

  • CNW Group4 months ago

    Khiron Life Sciences Corp. Announces Formation of Wellness Business Unit and the Launch of Its First CBD Cosmeceutical Brand

    TORONTO , Sept. 28, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V) (KHRNF) (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today the creation of Khiron Wellness, and the launch of Kuida®, its first CBD-based skincare brand. With this achievement, Kuida® becomes the first mass-market CBD-based brand approved by INVIMA, Colombia´s health agency, and available for sale in Colombia . Khiron's Wellness business unit is focused on cosmeceutical and nutraceutical products, offering the full benefits of cannabis to consumers across Latin America .

  • CNW Group4 months ago

    Khiron Life Sciences Signs Non-Binding MOU to Enter Chilean Medical Cannabis Market with Country's Only Licensed Producer, Fundacion Daya and DayaCann

    TORONTO , Sept. 27, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V) (KHRNF) (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has signed a non-binding memorandum of understanding with Fundacion Daya, Chile's leading medical cannabis institution and the holder of Chile's only medical cannabis license through DayaCann, a joint venture entity established between Fundacion Daya and AusCann Group Holdings Ltd.

  • CNW Group4 months ago

    Khiron Life Sciences Announces Incorporation into Horizons Emerging Marijuana Growers Index ETF

    Khiron Life Sciences Announces Incorporation into Horizons Emerging Marijuana Growers Index ETF

  • CNW Group4 months ago

    Khiron Life Sciences Director and Former President of Mexico, Mr. Vicente Fox to Present Keynote Address at Global Cannabis Business Conference in Jamaica

    Khiron Life Sciences Director and Former President of Mexico, Mr. Vicente Fox to Present Keynote Address at Global Cannabis Business Conference in Jamaica